GlaxoSmithKline Consumer Nigeria Plc Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
For the six months, sales was NGN 14,811.27 million compared to NGN 9,862.41 million a year ago. Net income was NGN 349.35 million compared to NGN 59.91 million a year ago. Basic earnings per share from continuing operations was NGN 0.29 compared to NGN 0.05 a year ago. Diluted earnings per share from continuing operations was NGN 0.29 compared to NGN 0.05 a year ago.